European Companies Search Engine
Omega Therapeutics Inc., Cambridge, United States
Watch
If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.
Dossier
The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .
Add to dossier (if available):
Name
Omega Therapeutics Inc.
Identification
Stockp
OMGA
Address
Corporate purpose
2836
Biological Products, (No Diagnostic Substances)
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a, a transcriptional master regulator as a potential way to restore liver-cell function in patients suffering from chronic liver diseases; to control the expression of genes that have been strongly linked to cell-growth … Show more
History
Network
Loading network
Annual report
Publications
There are no publications matching your search.
The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.
The visualizations for "Omega Therapeutics Inc., Cambridge, United States"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
